GSK

GSK plc - ADR

46.60

USD

+0.05

+0.11%

Oct 06, 15:59 UTC -4

Closed

After-Market

46.59

-0.01

-0.01%

GSK plc - ADR Profile

About

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

Info & Links

CEO

Luke Miels

Headquarters

79 New Oxford Street
London, X0 WC1A 1DG, UNITED KINGDOM

Auditor

Deloitte LLP

Share holders

14,175

Employees

66,841

GSK plc - ADR Statistics

Valuation Measures

Market Capitalization²

93.35B

Enterprise Value

113.66B

Enterprise Value/EBITDA(ttm)

8.88

Price to Earnings Ratio(ttm)

9.88

Price to Sales(ttm)

2.14

Price to Book(mrq)

4.13

Price to Cash(ytd)

7.83

Profitability

Gross Margin(ttm)

72.82%

Operating Margin(ttm)

21.54%

Profit Margin(ttm)

14.74%

Return on Equity(ttm)

43.23%

Return on Invested Capital(ttm)

17.03%

Return on Assets(ttm)

11.60%

Income Statement

Revenue(ttm)

44.51B

Revenue Per Share(ttm)

Gross Profit(ttm)

32.38B

EBITDA(ttm)³

12.80B

Net Income Available to Common(ttm)

6.49B

Diluted EPS(ttm)

3.20

Share Statistics

Beta (5Y Monthly)

0.33

52-Week Change

7.50%

S&P 500 52-Week Change

19.75%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

3.78%

Float⁴

1.82B

% Held by Insiders

10.00%

% Held by Institutions

15.74%

Balance Sheet

Total Cash(mrq)

4.29B

Total Cash Per Share(mrq)

Total Debt(mrq)

24.48B

Total Debt/Equity(mrq)

106.18%

Current Ratio(mrq)

0.82%

Quick Ratio(mrq)

0.52%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

2.53

Free Cash Flow(ytd)

4.45B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GSK